(Q54525535)

30 May 2018

editorial

0 references

title

PKCθ: a new target for selective immunosuppression. (English)

1 reference

30 May 2018

1 reference

Amnon Altman

1

1 reference

30 May 2018

Kok-Fai Kong

series ordinal

2

1 reference

30 May 2018

publication date

1 March 2012

1 reference

30 May 2018

Expert Review of Clinical Immunology

published in

1 reference

30 May 2018

volume

8

1 reference

30 May 2018

issue

3

1 reference

30 May 2018

page(s)

205-208

1 reference

30 May 2018

Protein kinase C theta (PKCtheta): a key player in T cell life and death

cites work

1 reference

PKCtheta signals activation versus tolerance in vivo

21 January 2018

1 reference

Protein kinase C η is required for T cell activation and homeostatic proliferation

21 January 2018

1 reference

T-cell fate and function: PKC-theta and beyond

21 January 2018

1 reference

PKCtheta is required for alloreactivity and GVHD but not for immune responses toward leukemia and infection in mice

21 January 2018

1 reference

Common and different genetic background for rheumatoid arthritis and coeliac disease

21 January 2018

1 reference

Meta-analysis of genome-wide association study data identifies additional type 1 diabetes risk loci

21 January 2018

1 reference

Protein kinase C theta is highly expressed in gastrointestinal stromal tumors but not in other mesenchymal neoplasias.

21 January 2018

1 reference

PKC inhibitors: potential in T cell-dependent immune diseases

21 January 2018

1 reference

The role of stem cells in vein graft remodelling

21 January 2018

1 reference

Sotrastaurin, a novel small molecule inhibiting protein-kinase C: randomized phase II study in renal transplant recipients.

21 January 2018

1 reference

The PKC inhibitor AEB071 may be a therapeutic option for psoriasis.

21 January 2018

1 reference

The potent protein kinase C-selective inhibitor AEB071 (sotrastaurin) represents a new class of immunosuppressive agents affecting early T-cell activation.

21 January 2018

1 reference

Effects of the new immunosuppressive agent AEB071 on human immune cells.

21 January 2018

1 reference

Effects of the novel protein kinase C inhibitor AEB071 (Sotrastaurin) on rat cardiac allograft survival using single agent treatment or combination therapy with cyclosporine, everolimus or FTY720.

21 January 2018

1 reference

PKC theta cooperates with PKC alpha in alloimmune responses of T cells in vivo

21 January 2018

1 reference

The immunological synapse: a molecular machine controlling T cell activation

21 January 2018

1 reference

Selective modulation of protein kinase C-theta during T-cell activation

21 January 2018

1 reference

A motif in the V3 domain of the kinase PKC-θ determines its localization in the immunological synapse and functions in T cells via association with CD28

21 January 2018

1 reference

Protein kinase C-theta mediates negative feedback on regulatory T cell function

21 January 2018

1 reference

PKC-θ is required for TCR-induced NF-κB activation in mature but not immature T lymphocytes

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ECI.12.8

1 reference

30 May 2018

1 reference

30 May 2018